dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 5. märts 2025
Viit
REP-1/1197-1
Registreeritud
5. märts 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: teisipäev, 4. veebruar 2025 13:13 Adressaat: Signe Leito Teema: Survey: Addition to the WP of Group 17: Sodium Patent Blue and Sodium Patent Blue solution for injection : EDQM-2025-00566-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of the monographs on Sodium Patent Blue and Sodium Patent Blue solution for injection to the work programme of Group 17. In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=554777&lang=en Deadline for replies: 7 March 2025. Thank you. With kind regards On behalf of Amela Saracevic ___ Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 1 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail 2
Allikas: Ravimiamet dokumendiregister →